Using an expression cloning approach, we have isolated a cDNA encoding GD3 synthase (CMPNeuAc:NeuAca2-3GalJ1-4Glcf8l-1'Cer a2,8-sialyltransferase, EC 2.4.99.8), which is a key regulatory enzyme determining the prominence of the gangloide biosynthesis pathway. The cloned cDNA encodes a 341-amino acid protein containing a single transmembrane domain at its N-terminal region, suggesting that the protein has a type H transmembrane topology. The sequence of a2,8-sialyltransferase showed a high level ofsimilarity with other sialyltransferases at two conserved regions typical in the sialyltransferase family. Transfected cells containing the cloned cDNA expressed GD3 ganglioside on the cell surface, which was detectable with specific anti-GD3 antibody by immunofluorescence and immunotaining after separation of isolated glycolipids on thin-layer chromatography. The cDNA hybridized to a single mRNA species of 2.4 kb in melanoma cells. This sialyltransferase is distinctive in catalyzing the formation of the a2-8 linkage of sialic acids.important to isolate the gene coding for a2,8-sialyltransferase for understanding of the biological roles of sialic acid in glycoconjugates.To clone the cDNA of a2,8-sialyltransferase responsible for synthesis of GD3 ganglioside, which is the first ganglioside in the synthetic pathway having sialyl-a2, Gangliosides are membrane-bound glycosphingolipids containing sialic acids that are found in high concentrations on the central nervous system. The carbohydrate moieties of gangliosides undergo profound changes during mammalian development, differentiation, and malignant transformation, suggesting that they may play fundamental roles in these processes (for reviews see refs. 2 and 3 and references therein). In particular, the GD3 ganglioside has been shown to be important for cell adhesion and growth of cultured malignant cells (4, 5) and the inductive epithelial-mesenchymal interaction in the kidney development (6). Although these ganglioside biological phenomena have been known, the mechanism regulating ganglioside expression remains unclear. To address this question, cloned genes that determine ganglioside expression are essential tools.Ganglioside biosynthesis takes place in the Golgi apparatus, where glucosylceramide is glycosylated by sequential addition of galactose, N-acetylgalactosamine, and N-acetylneuraminic acid (7). These reactions are catalyzed by specific glycosyltransferases. Recently, several glycosyltransferase cDNAs responsible for glycolipids and glycoproteins have been cloned (for reviews, see refs. 8 and 9), and the regulation of cell-type-specific expression of glycosyltransferases is being intensively investigated (9). With regard to sialyltransferases, there is a family of more than 12 different enzymes showing different substrate specificities (9). To date, cDNAs of 5 different sialyltransferases have been cloned (10-16), but a sialyltransferase responsible for the sialyl-a2,8-sialyl linkage, which appears in poly(sialic acid) in glycoconjugates, has not yet b...